These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6518923)

  • 1. [Detection of theophylline in human serum and its clinical application].
    Li LS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Jun; 7(3):139-42, 190. PubMed ID: 6518923
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of the serum level of theophylline in a group of patients with chronic obstructive bronchopneumopathy].
    Marzo C; Gnasso P; Dericoloso A; Borrelli G; Vacca C; Cantone F
    Arch Monaldi; 1981; 36(1-2):71-5. PubMed ID: 7348162
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
    [No Abstract]   [Full Text] [Related]  

  • 6. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
    Ranke C; Schmidt G; Oellerich M; Sybrecht GW
    Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of theophyllinemia in patients with obstructive bronchial syndrome].
    Vasiliev CB; Burnea D; Vasiliev R; Popescu C; Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(2):169-80. PubMed ID: 6316471
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of the pharmacokinetic determination of theophylline].
    Gao L
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):137-40, 188. PubMed ID: 3094865
    [No Abstract]   [Full Text] [Related]  

  • 9. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1986 Aug; 40(8):334-8. PubMed ID: 3748986
    [No Abstract]   [Full Text] [Related]  

  • 10. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
    Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Blinov IL
    Ter Arkh; 1993; 65(2):52-4. PubMed ID: 9133013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The evaluation in primary care of blood theophylline in patients with chronic obstructive pulmonary disease].
    Isanta Pomar C; Subías Lorén P; Baquer Masgrau A; Auría Romeo C; Martín Moros JM; Izquierdo Clemente C
    Rev Clin Esp; 1991 Jun; 189(1):42-3. PubMed ID: 1924930
    [No Abstract]   [Full Text] [Related]  

  • 12. [Theophyllin-dosage in adults; blood level determination as therapeutic control].
    Lunde PK; Lange-Nielsen F; Brørs O
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):173-74. PubMed ID: 7385143
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline pharmacokinetics in patients with mild or severe airway obstruction.
    Rizzo A; Mirabella A; Ferrara G; Pipitone P; Bellia V; Bonsignore G
    Bull Eur Physiopathol Respir; 1982; 18(6):811-8. PubMed ID: 6927536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of theophylline clearance to design an oral aminophylline regimen.
    Simmons SM; Camp RB; Mungall DR; Bailey WC
    Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
    [No Abstract]   [Full Text] [Related]  

  • 16. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
    Nolte D; Dusik B
    Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
    [No Abstract]   [Full Text] [Related]  

  • 17. [Norfloxacin does not raise theophylline concentrations in plasma].
    Tamura G; Satoh K; Ohtsu H; Fujimoto Y; Aizawa T; Sakai K; Mue S; Takishima T
    Arerugi; 1987 May; 36(5):262-7. PubMed ID: 3662833
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of determining theophylline concentration in serum].
    Bonelli J; Dellinger C; Kraus M; Waginger H; Zanic P
    Wien Med Wochenschr; 1986 Dec; 136(23-24):641-6. PubMed ID: 3564492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.